MYC and neoplasm: To understand whether these treatments were altering the immune populations in the whole brain, mice harboring Myc/p53DD tumors were administered treatment (or control) as described above, and the immune cells present in brain tissue were assessed by flow cytometry when mice required euthanasia due to tumor-related morbidity, using the gating strategy defined in Figure 2.